Patent assignee · US · COMPANY

Stemden USA, LLC

1Patents
1Active
1Granted
37Portfolio score

Filing activity: Aug 9, 2019 → Aug 9, 2019

Most-cited patents

PatentTitleAreaCited byStatus
US12090166B2 Pharmaceutical composition for preventing or treating dentin-dental pulp disease or periodontal disease, containing LPAR2 inhibitor Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.